公司资料

Genprex 股价、新闻与催化剂

股票代码:: GNPX
交易所:: NASDAQ
行业:: Biopharma
所在地:: United States

股票表现

4.47 USD (+3.59%)

收盘价

最后更新: 2026年8月17日

7.78M USD

市值

股价为何变动

As of Aug 17, 2026, GNPX closed up 3.59% at $4.47. No new same-company headline was identified in the current news window.

公司概览

业务概览

Genprex is a gene-therapy and oncology company focused on cancer and diabetes-related programs. Its platform has long centered on genetic medicine in difficult disease settings.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ, Genprex sits in specialty biotechnology.

商业模式特征

The company depends on platform validation, clinical progress, and the ability to translate gene-delivery science into value.

生物医药行业定位

Genprex is a high-catalyst genetic-medicine name with strong dependence on early results.

未来催化剂

Genprex’s catalysts are the oncology and diabetes platforms, plus any strategic update that shows the company can still create value. The market needs a more convincing clinical path.